LYNCH DANIEL

Track

Insider profile

LYNCH DANIEL's trades of Springworks Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
58.59
Quantity 48,000
Value US$2,812,320
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-24 2025-02-20
PlS Planned sale
70,270 -34.1%
168.89
US$3,002,809 		70,270 -34.1% 168.89 US$3,002,809
2025-02-24 2025-02-20
PlS Planned sale
69,079 +3.5%
460.86
US$3,676,733 		69,079 +3.5% 460.86 US$3,676,733
2025-02-19 2025-02-14
PlS Planned sale
38,833 +25.6%
350.73
US$1,788,717 		38,833 +25.6% 350.73 US$1,788,717
2025-02-14 2025-02-14
PrS Proposed sale
48,000
58.59
US$2,812,320 		48,000 58.59 US$2,812,320
2025-02-12 2025-02-10
PlS Planned sale
65,600 -33.4%
55.51
US$3,641,751 		65,600 -33.4% 55.51 US$3,641,751
2025-02-12 2025-02-10
PlS Planned sale
39,634 -16.8%
54.88
US$2,175,047 		39,634 -16.8% 54.88 US$2,175,047
2025-02-12 2025-02-10
PlS Planned sale
69,766 -22.8%
53.23
US$3,713,553 		69,766 -22.8% 53.23 US$3,713,553
2025-02-10 2025-02-10
PrS Proposed sale
175,000
40.28
US$7,049,000 		175,000 40.28 US$7,049,000